Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats

Efficacy and Safety of Cyclosporine in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

(2018) Firdaus A. Rahman et al.   Frontiers in Pharmacology

Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling

(2017) Mónica P. A. Ferreira et al.   Small

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

(2016) Jung Soo Suk et al.   ADVANCED DRUG DELIVERY REVIEWS

In vitro and in vivo assessment of heart-homing porous silicon nanoparticles

(2016) Mónica P.A. Ferreira et al.   BIOMATERIALS

Cyclosporine A, a Potential Therapy of Ischemic Reperfusion Injury. A Common History for Heart and Brain

(2016) Norbert Nighoghossian et al.   CEREBROVASCULAR DISEASES

A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics

(2016) Guillermo U. Ruiz-Esparza et al.   EUROPEAN JOURNAL OF HEART FAILURE

Ischaemic conditioning and reperfusion injury

(2016) Derek J. Hausenloy et al.   Nature Reviews Cardiology

YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α

(2016) Yichao Zhao et al.   Scientific Reports

Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives

(2015) Deepti Pandita et al.   DRUG DISCOVERY TODAY

Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin

(2015) Jing-Kun Yan et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Cyclosporine before PCI in Patients with Acute Myocardial Infarction

(2015) Thien-Tri Cung et al.   NEW ENGLAND JOURNAL OF MEDICINE

PLGA-Based Nanoparticles: a Safe and Suitable Delivery Platform for Osteoarticular Pathologies

(2015) Mathieu Riffault et al.   PHARMACEUTICAL RESEARCH

Cyclosporine Protects the Heart during Aortic Valve Surgery

(2014) Pascal Chiari et al.   ANESTHESIOLOGY

Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1

(2014) Xiwei Ding et al.   BMC CANCER

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

(2013) Hazel H Szeto   BRITISH JOURNAL OF PHARMACOLOGY

An Update on Cardioprotection

(2012) Paul Z. Gerczuk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia?

(2012) Michele Miragoli et al.   Nanomedicine

Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria‐Targeting Cytoprotective Peptide

(2012) Robert A. Kloner et al.   Journal of the American Heart Association

Studies on the hemocompatibility of bacterial cellulose

(2011) Fábia K. Andrade et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Nanoparticles Targeting the Infarcted Heart

(2011) Tal Dvir et al.   NANO LETTERS

Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury

(2009) Masao Saotome et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling

(2009) John W. Calvert et al.   CIRCULATION RESEARCH

Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction

(2008) Christophe Piot et al.   NEW ENGLAND JOURNAL OF MEDICINE